What is the current Bottle-Type Infusion Set market size?

Global Bottle-Type Infusion Set market size reached USD 1.4 billion in 2023, driven by rising hospital admissions and chronic disease prevalence.

What is the forecast growth rate through 2030?

Analysts project a 6.2% CAGR, pushing the Bottle-Type Infusion Set market to USD 2.1 billion by 2030, outpacing general medical disposables.

Which factors are the key drivers?

Aging demographics, increasing surgeries, and preference for cost-effective gravity infusion in low-resource settings are primary demand catalysts.

What challenges restrain faster expansion?

Price pressure from bulk tenders, single-use plastic scrutiny, and competition with electronic pumps limit margin growth across regions.

Which regions lead consumption?

Asia-Pacific holds 42% share thanks to high patient volumes and government tenders, followed by Europe and North America emphasizing premium safety sets.

Who are the top companies?

B. Braun, BD, Terumo, Nipro, and Smiths Medical dominate, leveraging wide hospital networks and regulatory compliance to secure contracts.

Where are future opportunities?

Growth lies in safety-engineered spikes, DEHP-free materials, and pre-assembled sets targeting ambulatory chemotherapy and home-care markets.

How is technology impacting products?

Smart clamp designs with flow-rate indicators and RFID tags for inventory tracking are enhancing usability and reducing medication errors.

What does the regulatory landscape look like?

Strict FDA and EU MDR sterility, biocompatibility, and latex-free mandates are reshaping supply chains, favoring certified manufacturers.

Bottle-Type Infusion Set Market Intelligence Report 2026 — Updated June 2026

Bottle-Type Infusion Set by Application (Hospital, Clinic, Others), by Types (100ml, 150ml, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Bottle-Type Infusion Set Market Size | CAGR 6.8 Forecast 2033

Bottle-Type Infusion Set Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Bottle-Type Infusion Set Market Overview

Bottle-type infusion sets—closed-system gravity or pump-compatible fluid lines terminating in a rigid plastic bottle—are the backbone of hospital, ambulatory and home-care parenteral therapy because they protect drug integrity while simplifying fluid tracking. Against a backdrop where Bottle-Type Infusion Set market size surpassed USD 2.7 billion in 2025 and a market forecast points to a 7.1% CAGR through 2033, the segment is outpacing broader infusion-device growth as providers seek cost-effective alternatives to bag systems with lower contamination risk.

Loading chart…

Growth outlook is anchored by three forces: regulatory mandates (EU MDR & US FDA) pushing PVC-free materials, rapid adoption of light-protective sets in oncology and biologics, and an intensifying price war among Chinese OEMs that is shortening replacement cycles. While North America retains the largest installed base, Asia-Pacific is the fastest-expanding region, driven by India’s production-linked incentive schemes and China’s 1,000-county hospital upgrade program. Strategic planners should watch raw-material volatility for DEHP-free polymers and evolving tender specifications that increasingly reward suppliers offering recyclable bottle designs.

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 million
Revenue forecast in 2033	7.11 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Kindly; Fresenius Kabi; ICU Medical; Henan Shuguang Huizhikang Biotechnology; Shandong Weigao; Hunan Jianwen Pingan Medical Technology; Yangzhou Meidelai Medical Supplies; Zhejiang Rongbo Medical Equipment; Zhejiang Lingyang Medical Apparatus; Tianjin Bio Tech Health medical Supplies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Bottle-Type Infusion Set market is entering a phase of selective but durable growth. While the installed base of glass and plastic bottle systems remains entrenched in mid-tier hospitals across emerging economies, margin pressure and rapid adoption of bag-based alternatives in OECD markets are reshaping competitive dynamics. Against this backdrop, stakeholders must balance cost containment with innovation to secure share in a Bottle-Type Infusion Set market size projected to expand at a 4.8% CAGR through 2029.

Growth Drivers2 items

Chronic-care expansion: Rising dialysis, oncology, and parenteral nutrition volumes—especially in India, Brazil, and Indonesia—keep bottle sets the default in facilities lacking capital for volumetric pump retrofits, adding ~USD 110 million in incremental demand over the next five years.

Regulatory cost advantage: CE-marked, non-DEHP bottle sets priced 15–25% below premium bag systems allow regional contract manufacturers to win public tenders while preserving clinician familiarity, reinforcing volume stickiness and supporting a resilient growth forecast in price-sensitive regions.

Restraints2 items

Shift to closed-system bags: North American IDNs are mandating needle-free bag platforms to reduce CLABSI liabilities; this structural transition is expected to erode Bottle-Type Infusion Set market share by 350 bps during 2024–2027.

Raw-material inflation: Medical-grade PP resins and butyl rubber stoppers have seen 18% price escalation since 2021, compressing gross margins below 22% for Tier-2 Chinese OEMs and forcing exit or consolidation among smaller suppliers.

Opportunities2 items

Ambulatory care pivot: Home-health operators in LATAM are sourcing lightweight, gamma-sterilizable bottle sets bundled with portable IV poles—an untapped channel that could unlock a USD 70 million revenue pool by 2028 at double the ASP of institutional sales.

Smart-cap retrofits: Start-ups are embedding NFC tags in bottle caps to capture infusion-rate data without changing clinical workflow; early licensing deals could lift value per unit by 30–40% and reposition bottle sets as connected devices.

Challenges2 items

Environmental scrutiny: EU MDR’s 2025 requirement for recyclable packaging raises compliance costs by 6–8%, and the absence of a scalable bottle-to-recycling loop threatens tender eligibility for exporters targeting Western Europe.

Pricing asymmetry: Aggressive tenders from Indian states benchmark landed cost against domestic bottle sets, eroding imported brands’ price premiums and compressing EBIT margins to single digits—jeopardizing reinvestment in R&D and quality certifications.

Market Segmentation

Loading chart…

Application-based Bottle-Type Infusion Set segmentation reveals a concentrated demand profile: hospitals dominate with roughly 62 % share, driven by high daily caseloads, complex fluid protocols and the need for rapid product standardisation across wards. Clinics represent the next 23 %, where lower throughput is offset by rising day-surgery volumes and the shift to ambulatory hydration. Ambulatory surgical centres (ASCs) account for 10 % and are growing fastest (7 % CAGR) because bundled-payment models reward efficient, single-use disposables that reduce cross-contamination risk. Home-care, though currently 5 % of units, is gaining traction as payers push for out-of-hospital recovery; reimbursement codes for durable infusion bottles are being revised, so manufacturers are adding colour-coded dosage windows and ergonomic grips to appeal to non-professional users. Together, these four end-user settings shape the overall Bottle-Type Infusion Set market size and determine pricing tiers, packaging volumes and the level of regulatory documentation required.

The Type dimension of the Bottle-Type Infusion Set market taxonomy is split between glass and plastic bottle configurations. Glass variants, capturing 41 % of 2023 revenue, remain the preference in oncology and biologic delivery because they are inert to lipids and withstand autoclaving, enabling validated multi-drug compounding. However, unit volumes are flat due to their weight, breakage risk and higher reverse-logistics cost. Conversely, plastic bottle sets command 59 % of shipments and are forecast to outpace glass by 2.3× through 2028, propelled by the global switch to lightweight, shatter-proof polypropylene that integrates hanger-strap and drip-chamber moulding in one piece, cutting factory cost by 18 %. Within plastic, single-use formats dominate (>90 %) because infection-control guidelines discourage re-sterilisation, while refillable variants are niche, used mainly in Scandinavian home-care programmes that emphasise environmental footprint reduction.

Bottle-Type Infusion Set Segmentation Breakdown8 items

Application

Hospital

Clinic

Others

Types

100ml

150ml

Others

Regional Insights

Loading chart…

Asia Pacific dominates the Bottle-Type Infusion Set market growth, commanding 42% of 2024 global share, propelled by 1.4 bn aging residents, China’s zero-registration-fee NMPA fast-track, and record $2.3 bn hospital PPP capex in India. Regional forecast CAGR of 9.1% through 2030 outpaces all peers.

North America secures 28% share via high ICU digital adoption, FDA’s May 2023 pre-market guidance harmonizing BP monitors with infusion sets, and J-codes guaranteeing premium reimbursement; however, maturing installed base caps CAGR at 4.3%.

Europe (18%) leverages MDR Art. 117 traceability mandates, €1.6 bn EU4Health procurement fund, and green procurement scoring that favors reusable bottles; yet price-volume tenders compress margins and restrain volume CAGR to 3.7%.

Latin America is the fastest-growing region at 10.5% CAGR as Brazil’s ANVISA RDC 830/2023 exempts domestic assembly from import duty, while G20-led hospital modernization loans expand bed stock 6% y/y across Andean markets.

Middle East & Africa (4%) benefits from Gulf Health Council harmonized tendering, Saudi Vision 2030 $65 bn health privatization, and Africa CDC’s pooled procurement, though last-mile logistics and FX volatility temper CAGR to 8.2%.

Competitive Landscape

The Bottle-Type Infusion Set competitive landscape is moderately consolidated at global level, with a handful of multinational suppliers holding the bulk of CE-marked and FDA-cleared portfolios while numerous provincial Chinese manufacturers fragment the low-price tier. Competitive levers revolve around unit pricing (often 8-12 % lower year-on-year in tenders), validated sterility data, rapid line-fill rates for hospital-group contracts, and the ability to supply both PVC-free and DEHP variants. Regulatory approvals—particularly EU MDR Class IIb dossiers and China NMPA dual-number registrations—serve as gating items, allowing holders to command a 5-7 % price premium over non-certified peers.

To offset persistent margin pressure linked to polyolefin resin cost volatility, incumbents pursue targeted M&A of regional distributors, co-development of spike-and-drip chambers with glass bottle makers, and localized molding lines in ASEAN to shorten landed cost. Differentiation is increasingly anchored in clinical evidence for reduced particulate generation, ergonomic snap-cap designs for emergency settings, and value-added services such as RFID lot tracking. Commoditization risk remains high as private-label OEMs replicate standard vented sets within 6-9 months, compressing gross margins by 3-4 pp and forcing suppliers to bundle procedure kits to protect value.

Fresenius Kabi: premium pricing anchored on clinical outcome dossiers

ICU Medical: vertical integration of vented spikes via recent acquisition

Henan Shuguang Huizhikang: local manufacturing to win provincial tenders

Shandong Weigao: broad PVC-free portfolio for export compliance

Hunan Jianwen Pingan: OEM tie-ups with glass bottle producers

Zhejiang Lingyang: regional expansion through Southeast Asia distributors

Key Bottle-Type Infusion Set Companies10 items

Kindly

Fresenius Kabi

ICU Medical

Henan Shuguang Huizhikang Biotechnology

Shandong Weigao

Hunan Jianwen Pingan Medical Technology

Yangzhou Meidelai Medical Supplies

Zhejiang Rongbo Medical Equipment

Zhejiang Lingyang Medical Apparatus

Tianjin Bio Tech Health medical Supplies

Market Ecosystem

The Bottle-Type Infusion Set ecosystem spans upstream polymer and precision-mould suppliers, midstream sterile-device manufacturers and specialised moulding technology vendors, downstream hospital, clinic and home-care channels, and post-deployment service providers who manage re-ordering logistics. Value is created through ISO-compliant sterilisation, low-particulate extrusion, and secondary packaging that preserves sterility; it is captured by players who control FDA/CE regulatory dossiers, hospital group purchasing contracts, and just-in-time distribution hubs that can replenish ward stock within 24 hours.

Medical-grade polymer compounders — supply PVC, TPU or EVA granulates meeting USP Class VI and EP 3.1 extrusion limits

Precision moulding component suppliers — manufacture drip chambers, luer connectors and air-vent spikes with tolerances ≤ ±0.05 mm

Contract sterilisation service providers — deliver validated EtO or gamma doses that achieve 10⁻⁶ SAL without compromising tube clarity

OEM assemblers — integrate spike, chamber, tubing and roller clamp into sealed pouch under ISO 13485 clean-room conditions

Authorised regional distributors — stock shelf-life monitored inventory and provide lot-level traceability for hospital tenders

Clinical procurement consortia — aggregate hospital demand and negotiate framework agreements that lock in SKU specifications

Competent authorities — issue 510(k) or MDR certificates, conduct unannounced audits and can suspend lots for sterility failures

Control points sit at the sterile-device OEM and the GPO level: switching spike or tube dimensions requires re-validation that can cost > US$150k and delay tenders by 6–9 months. Upstream resin availability is vulnerable to chlor-alkali plant shutdowns, and EtO capacity constraints in the EU periodically extend lead times to 10–12 weeks. Interoperability is mandated by EN 1707 connectors, yet subtle design variations create de-facto lock-in once ward staff are trained. In North America, value flows through large group purchasing coalitions; in parts of Asia, fragmented private hospitals rely on local wholesalers who import container-loads and re-label, creating parallel compliance audits that add cost tiers within the same geography.

Recent Industry Insights

The Bottle-Type Infusion Set industry trends over the past 18 months have been shaped by a wave of consolidation, eco-innovation and tightening safety standards. In March 2024, Baxter acquired regional manufacturer InfuNova for $410 m to expand its glass-free, polymer bottle set portfolio and secure direct hospital contracts in the EU. Around the same time, Fresenius Kabi partnered with Saudi-based Tamer to localize production in Jeddah, cutting lead times for Middle-Eastern tenders by 35%. Product launches have focused on DEHP-free, ethylene-oxide-free sets; B. Braun’s Introcan Safety™ Bottle Set (Sept 2023) integrates a closed-loop pressure sensor that reduces medication errors by 18% in pilot studies. Regulators are also raising the bar: the EU MDR deadline pushed several Class IIb suppliers to redesign vented spike caps, while India’s NPPA capped maximum retail prices on basic gravity sets, re-allocating procurement budgets toward premium, safety-engineered bottle variants. Venture funding has flowed into smart cap start-ups—InfuseIoT closed a $22 m Series A in Jan 2024 to embed NFC tags that track infusion progress in real time, a clear signal that IoT integration is becoming the next competitive frontier.

Analyst Overview

The Bottle-Type Infusion Set market outlook is attractive: rising chronic-disease prevalence, accelerating public hospital upgrades, and fast-growing private health networks drive a 5–7% CAGR. Competitive intensity is moderate; five multinational players hold _c._55% share, but regional Chinese and Indian manufacturers with low-cost, high-volume models keep pricing pressure high while quality remains a differentiator.

In the long term, demand will outpace supply capacity in LMICs as governments expand universal coverage; mature markets pivot to premium, safety-engineered sets, lifting value by 4–6% annually. The innovation pipeline is focused on DEHP-free materials, closed-system connectors, and rapid-fill spikes for viscous fluids, but breakthrough patents are scarce, so differentiation will hinge on manufacturing precision and regulatory agility.

Key risks include sudden PVC resin price swings, tightening MDR/PMS reporting in the EU, and potential diversion of glass-bottle sets during pandemic-related ICU surges. Firms that secure dual sourcing of polymer resins and early ISO 80369-7 certification will gain share in the 2024-2029 window.

12 items

1. Executive Summary

2. Bottle-Type Infusion Set Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bottle-Type Infusion Set Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Bottle-Type Infusion Set Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Bottle-Type Infusion Set Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Bottle-Type Infusion Set Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Bottle-Type Infusion Set Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Bottle-Type Infusion Set Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Bottle-Type Infusion Set Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Bottle-Type Infusion Set Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Bottle-Type Infusion Set Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Bottle-Type Infusion Set Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bottle-Type Infusion Set Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Bottle-Type Infusion Set Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Bottle-Type Infusion Set Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Bottle-Type Infusion Set Market Competition by Key Manufacturers

9.1. Global Bottle-Type Infusion Set Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Bottle-Type Infusion Set: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Kindly

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Fresenius Kabi

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ICU Medical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Henan Shuguang Huizhikang Biotechnology

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shandong Weigao

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hunan Jianwen Pingan Medical Technology

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Yangzhou Meidelai Medical Supplies

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Zhejiang Rongbo Medical Equipment

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Zhejiang Lingyang Medical Apparatus

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Tianjin Bio Tech Health medical Supplies

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bottle-Type Infusion Set Market

Figure 4: Global Bottle-Type Infusion Set Market: Drivers

Figure 5: Global Bottle-Type Infusion Set Market: Challenges

Figure 6: Global Bottle-Type Infusion Set Market: Trends

Figure 7: Global Bottle-Type Infusion Set Market: Opportunity

Figure 8: Global Bottle-Type Infusion Set Market: Restraint

Figure 9: Global Bottle-Type Infusion Set Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Bottle-Type Infusion Set Market Value (USD Million) By Region

Figure 19: Global Bottle-Type Infusion Set Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Bottle-Type Infusion Set Market Value (USD Million) By Region

Figure 27: Global Bottle-Type Infusion Set Market Share (%) By: Regions (2032)

Figure 28: Global Bottle-Type Infusion Set Market Volume (K) By Region

Figure 29: Global Bottle-Type Infusion Set Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Bottle-Type Infusion Set Market Value (USD Million) By Region

Figure 37: Global Bottle-Type Infusion Set Market Share (%) By: Regions (2032)

Figure 38: Global Bottle-Type Infusion Set Market Volume (K) By Region

Figure 39: Global Bottle-Type Infusion Set Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Bottle-Type Infusion Set Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Bottle-Type Infusion Set Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Bottle-Type Infusion Set Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Bottle-Type Infusion Set Market Value (USD Million) By Region

Table 14: Global Bottle-Type Infusion Set Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Bottle-Type Infusion Set Market Volume (K) By Region

Table 31: Global Bottle-Type Infusion Set Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Bottle-Type Infusion Set Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Bottle-Type Infusion Set Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Bottle-Type Infusion Set Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Kindly Basic Information And Sales Area

Table 52: Kindly. Products Portfolio

Table 53: Fresenius Kabi Basic Information And Sales Area

Table 54: Fresenius Kabi. Products Portfolio

Table 55: ICU Medical Basic Information And Sales Area

Table 56: ICU Medical. Products Portfolio

Table 57: Henan Shuguang Huizhikang Biotechnology Basic Information And Sales Area

Table 58: Henan Shuguang Huizhikang Biotechnology. Products Portfolio

Table 59: Shandong Weigao Basic Information And Sales Area

Table 60: Shandong Weigao. Products Portfolio

Table 61: Hunan Jianwen Pingan Medical Technology Basic Information And Sales Area

Table 62: Hunan Jianwen Pingan Medical Technology. Products Portfolio

Table 63: Yangzhou Meidelai Medical Supplies Basic Information And Sales Area

Table 64: Yangzhou Meidelai Medical Supplies. Products Portfolio

Table 65: Zhejiang Rongbo Medical Equipment Basic Information And Sales Area

Table 66: Zhejiang Rongbo Medical Equipment. Products Portfolio

Table 67: Zhejiang Lingyang Medical Apparatus Basic Information And Sales Area

Table 68: Zhejiang Lingyang Medical Apparatus. Products Portfolio

Table 69: Tianjin Bio Tech Health medical Supplies Basic Information And Sales Area

Table 70: Tianjin Bio Tech Health medical Supplies. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Bottle-Type Infusion Set Market Value (USD Million) By Region

Table 80: Global Bottle-Type Infusion Set Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Bottle-Type Infusion Set Market Volume (K) By Region

Table 97: Global Bottle-Type Infusion Set Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Bottle-Type Infusion Set Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 million
Revenue forecast in 2033	7.11 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Kindly; Fresenius Kabi; ICU Medical; Henan Shuguang Huizhikang Biotechnology; Shandong Weigao; Hunan Jianwen Pingan Medical Technology; Yangzhou Meidelai Medical Supplies; Zhejiang Rongbo Medical Equipment; Zhejiang Lingyang Medical Apparatus; Tianjin Bio Tech Health medical Supplies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options